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Design: Nordic retrospective population-based cohort study. Data from national ART registries were cross-linked with national
medical birth registries.
Setting: Not applicable.
Patient(s): A total of 300,085 singleton deliveries: 39,919 after ART and 260,166 after SC.
Intervention(s): None.
Main Outcome Measure(s): Hypertensive disorders in pregnancy (HDP), placenta previa, cesarean delivery, preterm birth (PTB;
<37 weeks), low birth weight (LBW; <2,500 g), small for gestational age (SGA), and perinatal mortality (R28 weeks). Adjusted
odds ratios (AORs) were calculated. Associations between maternal age and outcomes were analyzed.
Result(s): The risk of placenta previa (AOR 4.11–6.05), cesarean delivery (AOR 1.18–1.50), PTB (AOR 1.23–2.19), and LBW (AOR 1.44–
2.35) was significantly higher in ART than in SC pregnancies for most maternal ages. In both ART and SC pregnancies, the risk of HDP,
placenta previa, cesarean delivery, PTB, LBW, and SGA changed significantly with age. The AORs for adverse neonatal outcomes at
advanced maternal age (>35 years) showed a greater increase in SC than in ART. The change in risk with age did not differ between
ART and SC for maternal outcomes at advanced maternal age.
Conclusion(s): Having singleton conceptions after ART results in higher maternal and neonatal outcome risks overall, but the impact
of age seems to bemore pronounced in couples conceiving spontaneously. (Fertil Steril 2016;106:1142–9.2016 by American Society
for Reproductive Medicine.)
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Fertility and Sterility®M any women today delay childbirth until theirfourth and fifth decades. According to Nordic Peri-natal Statistics the mean age at first delivery
increased from 23–24 years in 1975 to 28–29 years in 2012
in Denmark, Norway, and Sweden (1), and the same trend is
observed in most high-income countries. The reasons for
postponement of childbearing are probably multifactorial
and include better access to contraception, longer education,
later marriage, higher career goals, desire for financial stabil-
ity, and other social factors, as well as advances in assisted
reproductive technologies (ART). It is well established that
fecundity decreases rapidly with age >35 years and delayed
motherhood increases the demand for reproductive assis-
tance. Meanwhile, the introduction of new technologies,
such as oocyte donation and fertility preservation through
oocyte cryopreservation, to counteract the age-related decline
of fertility (also called social freezing) makes pregnancy
possible even at a very advanced maternal age. Yet, a higher
maternal age increases the risk of adverse maternal and
neonatal outcomes. The risk of preeclampsia and gestational
diabetes in women R45 years of age is two to three times
the risk for younger women (2–4). There is a higher risk of
preterm birth (PTB), low birth weight (LBW), and perinatal
mortality associated with higher maternal age, as well as an
increased risk of operative delivery (2, 3, 5). Many large
studies have also described the maternal and neonatal risks
related to ART (6–8). Although it is known that ART
increases the risk of maternal complications such as
hypertensive disorders in pregnancy (HDP), placenta previa,
and cesarean delivery, as well as the risk of poor neonatal
outcome, little is known about the interplay between age-
related and ART-related risks. Theoretically, advanced
maternal age in combination with ART could increase the
risks even further. The Committee of Nordic ART and Safety
(Conartas) cohort comprises all children born after ART in
the Nordic countries from 1982 to 2007 and gives a unique
opportunity to study maternal risks and neonatal outcome
of ART pregnancies at different maternal ages and compare
them with spontaneously conceived (SC) pregnancies (9).
The aim of the present study was to estimate the effect of
maternal age on maternal and neonatal complications in ART
compared with SC. In addition, we studied the effect of
maternal age separately within ART and SC pregnancies.MATERIALS AND METHODS
The Conartas study population is a population-based cohort
comprising data on all deliveries after ART in Sweden,
Denmark, Finland, and Norway from 1982 to 2007. Data
were obtained from each country's national ART and medical
birth registry and combined as described in detail previously
(9). Briefly, the IVF clinics in the Nordic countries are respon-
sible for reporting to national ART registries, and this report-
ing is mandatory. A personal identification number given to
all citizens allows linkage to the national medical birth regis-
tries. A comparison group, consisting of four control subjects
after SC, was selected for every ART child. In each country,
matching was performed for parity (primiparity or parity
>1) of the mother and year and month of birth of the child.VOL. 106 NO. 5 / OCTOBER 2016The comparison group comprised 332,915 SC singletons
(including all of the control subjects for ART singletons and
multiples). In this study, only fresh cycles with own oocytes
and singleton ART pregnancies from the Conartas cohort
were included. Data from Finland could not be included in
the present study, because it was not possible to discriminate
between fresh and frozen-thawed cycles in the Finnish
cohort. We excluded pregnancies with missing information
(n ¼ 4,460) and pregnancies with impossible or extreme
values on gestational age (<22þ0 weeks or R45þ0 weeks;
n ¼ 319) or birth weight (R7,000 grams; n ¼ 846). Pregnan-
cies with year of birth before 1988 were excluded owing to the
very small numbers. Only women aged 20–46 years were
included owing to the small number of reported ART births
in women <20 years of age and no reported ART births in
women >46 years of age. Thus, the present study population
consisted of 39,919 ART singleton deliveries and the control
group of 260,166 singleton deliveries after SC. In total,
300,085 singleton deliveries were included in the study.
For maternal complications, we used the International
Classification of Diseases, Ninth (ICD 9; 1987–1996) and
Tenth (ICD 10; 1997–2007) Revisions. The maternal compli-
cations analyzed included HDP (chronic hypertension with
superimposed preeclampsia, gestational hypertension, and
preeclampsia; ICD 9: 642 D–H, X; ICD 10: O11, O13–O16),
placental abruption (ICD 9: 641 C; ICD 10: O45), placenta pre-
via (ICD 9 641 A–B; ICD 10: O44), and cesarean delivery.
Neonatal outcome comprised PTB <37 weeks, PTB
<32 weeks, LBW <2,500 g, very low birth weight (VLBW;
<1,500 g), small for gestational age (SGA; >2 standard devi-
ations) below the gestational and sex-specific Swedish
growth standard (10), macrosomia (birth weight R4,500 g),
and perinatal mortality. Perinatal mortality was defined as
live birth with death from day 0 to 6 and stillbirth, both
restricted to pregnancies of R28þ0 weeks.
Information onmaternal and neonatal complications was
obtained from each country's national medical birth registry.
For ART pregnancies, information on date of embryo transfer,
fertilization method (in vitro fertilization (IVF), intracytoplas-
mic sperm injection (ICSI), or combination of IVF and ICSI),
and cryopreservation of embryos was obtained from the na-
tional ART registries.
For SC pregnancies, gestational age was defined accord-
ing to ultrasound investigation performed in the second
trimester or from the date of the last menstrual period if ultra-
sound had not been performed. In ART pregnancies, gesta-
tional age was calculated from the date of oocyte retrieval
or from ultrasound examination if the date of oocyte retrieval
was not available.Permission from Ethics Committees
The study was approved by the Data Protection Agency and
the authorities responsible for the relevant registers in each
participating country. Permission from ethics committees
was given in Norway (REK 2010/1909-11) and Sweden
(Regional Ethics Committee at the University of Gothenburg:








(n [ 260,166) P value
Country < .0001
Sweden 19,445 (48.7%) 123,389 (47.4%)
Denmark 12,440 (31.2%) 74,512 (28.6%)
Norway 8,034 (20.1%) 62,265 (23.9%)
Year of birth
1988–1992 1,602 (4.0%) 12,282 (4.7%)
1993–1997 5,996 (15.0%) 42,203 (16.2%)
1998–2002 12,613 (31.6%) 87,844 (33.8%)
2003–2007 19,708 (49.4%) 117,837 (45.3%)
Maternal age, y 33.3  4.0 28.8  4.7 < .0001
Maternal age, y (in categories)
<25 1,019 (2.6%) 66,647 (25.6%)
25 to <30 8,694 (21.8%) 102,497 (39.4%)
30 to <35 17,851 (44.7%) 67,186 (25.8%)
35 to <40 11,267 (28.2%) 21,081 (8.1%)
40 to <45 1,082 (2.7%) 2,721 (1.0%)
R45 6 (0.0%) 34 (0.0%)
Parity 1 (1; 2) 1 (1; 2) < .0001
Parity (in categories)
1 28,734 (72.0%) 177,667 (68.3%)
2 9,333 (23.4%) 52,275 (20.1%)
3 1,398 (3.5%) 21,413 (8.2%)
4 341 (0.9%) 5,961 (2.3%)
R5 113 (0.3%) 2,850 (1.1%)
Offspring sex .092
Male 20,624 (51.7%) 133,233 (51.2%)
Female 19,295 (48.3%) 126,933 (48.8%)
Birth weight, g 3,415  643 3,507  577 < .0001
Gestational age, d 276.3  16.3 278.9  13.7 < .0001
ART procedure
Fresh IVF 26,155 (65.5%) 0 (0.0%)
Fresh ICSI 13,720 (34.4%) 0 (0.0%)
Unknown or
combination
44 (0.1%) 0 (0.0%)
Note: Categoric variables are presented as n (%), continuous variables as mean  SD, and
parity as median (interquartile range). For comparisons between groups, Fisher exact test
was used for dichotomous variables, chi-square test nonordered categoric variables, and t
test for continuous variables. ART ¼ assisted reproductive technologies; SC ¼ spontaneous
conception.
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ORIGINAL ARTICLE: ENVIRONMENT AND EPIDEMIOLOGYStatistical Analyses
The association between maternal age and a binary outcome
was analyzed by means of logistic regression with the use of
generalized estimating equations (GEE) for estimation and tak-
ing correlationswithin individuals into account. To allow for the
effect of age to vary with age, piecewise logistic regression was
used. Breakpoints where the regression coefficients for age were
allowed to change were at 30, 35, and 40 years. With this model,
the odds ratio (OR) with age was assumed to be constant within
the age intervals<30, 30–35, 35–40, and>40 years but was al-
lowed to change between intervals. Owing to the small number
of events for perinatal mortality in women>40 years of age, the
breakpoint at 40 years was excluded in the models for this
outcome, resulting in models assuming a constant OR with
age R35 years. The OR of event for ART versus SC at selected
ages 30, 35, 40, and 45 years was estimated. Overall tests for
the effect of age and for difference between ART and SC were
carried out as contrasts of model parameters. Interaction ana-
lyses were carried out to test whether the OR with age for
advanced maternal age >35 years differed between ART and
SC. All analyses were adjusted for parity (continuous), year of
birth (continuous), offspring, sex, and country. All plots of pre-
dicted risk as functions ofmaternal agewere evaluatedwith par-
ity and year of birth set to the median values in the cohort and
with the use of weights on offspring sex and country according
to the distribution in the cohort. All tests were two tailed and
conducted at a 5% significance level, interpreting individual
tests as significant only if the corresponding overall test was sig-
nificant. Parameter estimates and contrasts of parameters were
tested by means of Wald tests with the use of the empirical
covariance matrix. All analyses were conducted with the use
of SAS System for Windows, version 9.4.
RESULTS
In total, 39,919 ART and 260,166 SC singleton pregnancies
(35,571 women in ART and 237,965 women in SC) were
analyzed. Baseline characteristics are described in Table 1.
The study flow chart is presented in Supplemental Figure 1
and the maternal age distributions of ORs in Supplemental
Figures 2–12 (available online at www.fertstert.org). The
mean maternal age for ART was 33.3 years (SD 4.0) and for
SC 28.8 years (SD 4.4). For all ages combined, the
occurrence of adverse outcomes was higher in ART than in
SC pregnancies. This applied to both maternal outcomes
(HDP, placental abruption, placenta previa, and cesarean
delivery) and most neonatal outcomes (PTB <37 and
<32 weeks, LBW, VLBW, SGA, macrosomia, perinatal
mortality R28 weeks; Table 2).
Maternal Outcomes
At 25 and 30 years of age, the risk of HDP was higher in ART
than in SC pregnancies (adjusted ORs [AORs] 1.42 and 1.13,
respectively). In ART there was a significant increase in
HDP from maternal age 35 to 40 years (AOR 1.35) and in
SC pregnancies up to 40 years of age (AORs 1.04–1.51). The
change in risk of HDP with age did not differ between ART
and SC at maternal age>35 years (P¼ .19, test for interaction;
Tables 3 and 4; Supplemental Fig. 2).1144The risk of placental abruption was significantly higher in
ART than in SC pregnancies at all ages except 45 years of age
(AORs 1.55–2.69). The risk of placental abruption did not
change by age in ART, whereas the risk increased from 30
and 35 years in SC pregnancies (AOR 1.26). The change in
risk of placental abruption with age did not differ between
ART and SC at advanced maternal age >35 years (P¼ .93,
test for interaction; Tables 3 and 4; Supplemental Fig. 3).
The risk of placenta previa was higher in ART than in SC
pregnancies at all ages except 45 years of age (AORs 4.11–
6.05). The risk of placenta previa in ART increased with age
up to 30 years of age (AOR 1.84) and up to 35 years of age
in SC pregnancies (AORs 1.72 and 1.88, respectively). The
change in risk of placenta previa with age did not differ be-
tween ART and SC at maternal age >35 years (P¼ .92, test
for interaction; Tables 3 and 4; Supplemental Fig. 4).
The risk of cesarean delivery was higher in ART than in SC
pregnancies at all ages except 45 years of age (AORs
1.18–1.50). There was a significant increase in the risk of ce-
sarean delivery with increasing age in both ART (AORs 1.17–VOL. 106 NO. 5 / OCTOBER 2016
TABLE 2





(n [ 245,600) P value
Hypertensive disorders
in pregnancy
2,281 (5.7%) 11,551 (4.7%) < .0001
Placental abruption 347 (0.9%) 1,129 (0.5%) < .0001
Placenta previa 635 (1.6%) 599 (0.2%) < .0001
Cesarean section 10,013 (25.1%) 40,092 (16.3%) < .0001
Preterm birth <37 wk 3,512 (8.8%) 13,819 (5.6%) < .0001
Preterm birth <32 wk 699 (1.8%) 2,111 (0.9%) < .0001
Low birth weight
<2,500 g
2,626 (6.6%) 9,607 (3.9%) < .0001
Very low birth weight
<1,500 g
633 (1.6%) 1,827 (0.7%) < .0001
Small for gestational
age
2,180 (5.5%) 10,477 (4.3%) < .0001
Birth weight
R4,500 g
1,225 (3.1%) 8,574 (3.5%) < .0001
Perinatal mortality
R28 wk
229 (0.6%) 1,016 (0.4%) < .0001
Note: For comparison between groups, Fisher exact test was used. ART¼ assisted reproduc-
tive technologies; SC ¼ spontaneous conception.
Wennberg. Age and obstetrical outcome in ART. Fertil Steril 2016.
Fertility and Sterility®1.85) and SC (AORs 1.36–1.86) pregnancies across the entire
range of maternal age. The change in risk of cesarean delivery
with age did not differ between ART and SC at maternal age
>35 years (P¼ .80, test for interaction; Tables 3 and 4;
Supplemental Fig. 5).
In general, the results of the unadjusted analyses were
similar to the results of the adjusted analyses (Supplemental
Tables 1 and 2, available online at www.fertstert.org).TABLE 3
Adjusted odds ratios (95% confidence intervals) for maternal and neonata
conception at selected maternal ages.




































































Note: Adjusted odds ratios (adjusted for parity, year of birth, sex of offspring, and country) are based
nologies versus spontaneous conception.
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VOL. 106 NO. 5 / OCTOBER 2016Neonatal Outcomes
The risk of PTB (<37 weeks and<32 weeks) was significantly
higher in ART than in SC singletons (PTB <37 weeks: AORs
1.23–2.19; PTB <32 weeks: AORs 1.68–3.20) except at
maternal age 45 years for PTB <37 weeks and at 40 and
45 years for PTB <32 weeks. The risk of PTB (<37 weeks
and<32 weeks) changed by age in both ART and SC pregnan-
cies, the risk decreasing significantly in ART up to 30 years of
age but not changing after 30 years. The risk of PTB
(<37 weeks and <32 weeks) increased in SC pregnancies
with maternal age from 30 to 40 years (PTB <37 weeks:
AORs 1.15 and 1.27, respectively; PTB <32 weeks: AORs
1.26 and 1.45, respectively). The change in risk of PTB
<37 weeks with age was significantly different between
ART and SC pregnancies in women of maternal age
>35 years (P¼ .043, test for interaction), with an increased
risk seen for SC >35 years, but not for ART pregnancies.
The change in risk of PTB <32 weeks with age did not differ
between ART and SC pregnancies at maternal age >35 years
(P¼ .36, test for interaction; Tables 3 and 4; Supplemental
Figs. 6 and 7).
The risk of LBW and VLBW was significantly higher in
ART than in SC singletons in all ages up to maternal age
40 years (LBW: AORs 1.44–2.35; VLBW: AORs 1.67–3.44).
The risk of LBW and VLBW in both ART and SC singletons
changed with maternal age. The risk decreased significantly
in ART up to 30 years of age but did not change after 30 years.
In SC singletons, the risk of LBW increased with maternal age
from 30 to 40 years (AORs 1.29 and 1.48, respectively) and the
risk of VLBW increased from 30 to 35 years of age (AOR 1.51).
The change in risk of LBWwith age was significantly differentl outcomes for assisted reproductive technologies versus spontaneous
















































































on piecewise logistic regression model. P values are presented for assisted reproductive tech-
1145
TABLE 4
Association betweenmaternal and neonatal outcomes andmaternal age in assisted reproductive technologies (ART) and spontaneous conception (SC): adjusted odds ratios [95%confidence intervals]
for event by 5-y increase in maternal age.
Outcome








P value<30 y 30 to <35 y 35 to <40 y ‡40 y
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Note: Adjusted odds ratios (adjusted for parity, year of birth, sex of offspring, and country) are based on piecewise logistic regression model.







































Fertility and Sterility®between ART and SC singletons in women of maternal age
>35 years of age (P¼ .0021, test for interaction), with an
increased risk for SC pregnancies at maternal age >35 years
but not for ART pregnancies. The change in risk of VLBW
with age did not differ between ART and SC singletons at
maternal age >35 years (P¼ .19, test for interaction;
Tables 3 and 4; Supplemental Figs. 8 and 9).
The risk of SGA was significantly higher in ART than in
SC singletons at 25 and 30 years (AORs 1.43 and 1.27, respec-
tively), and significantly lower at 40 and 45 years (AORs 0.83
and 0.23, respectively). The risks of SGA in ART and SC sin-
gletons changed by age. In ART there was a decrease before
30 years of age and an increase from 30 to 35 (AOR 1.24).
In SC singletons, there was a decrease before 30 years and
thereafter an increase (AORs 1.34–1.61). The change in risk
of SGA with age differed between ART and SC singletons at
maternal age >35 years (P< .0001, test for interaction),
with an increased risk seen for SC pregnancies at maternal
age >35 years, but not for ART pregnancies (Tables 3 and
4; Supplemental Fig. 10).
The risk of macrosomia was significantly lower in ART
than in SC singletons among women at 35 years of age
(AOR 0.76). The risk of macrosomia in ART did not change
with maternal age. In SC singletons, the risk was higher before
30 years (AOR 1.17) and lower at 35–40 years of age. The
change in risk of macrosomia with age differed between
ART and SC singletons at maternal age >35 years
(P¼ .0078, test for interaction), with the risk of macrosomia
decreasing with maternal age in SC pregnancies (Tables 3
and 4; Supplemental Fig. 11).
The risk of perinatal mortality was significantly higher
at 25 and 30 years in ART (AORs 1.68 and 1.53, respec-
tively) than in SC. Perinatal mortality in ART singletons
did not increase by maternal age, whereas it increased
with age from 30 to 35 years in SC pregnancies (AOR
1.60). The change in risk of perinatal mortality with age
did not differ between ART and SC pregnancies at maternal
age >35 years (P< .99, test for interaction; Tables 3 and 4;
Supplemental Fig. 12).
In general, the unadjusted analyses showed similar results
to the adjusted analyses (Supplemental Tables 1 and 2).DISCUSSION
In this large population-based Nordic cohort study, we eval-
uated maternal and neonatal risks associated with maternal
age in births resulting from ART as opposed to SC.
The risk of placental abruption, placenta previa, cesarean
delivery, PTB, very PTB, and VLBW was significantly higher
in ART pregnancies than in SC pregnancies for most maternal
ages. In both ART and SC pregnancies, the risk of HDP and ce-
sarean delivery increased in women of >35 years of age. The
change in risk of adverse maternal outcomes with age did not
differ between ART and SC pregnancies in women >35 years
of age. In ART singletons, the risk of adverse neonatal
outcomes did not increase in women>35 years of age, whereas
the risk of PTB, veryPTB, LBW, andSGA increased in SC single-
tons. The change in risk of PTB, LBW,andSGAwithagediffered
between ART and SC singletons in women >35 years of age.VOL. 106 NO. 5 / OCTOBER 2016The main strengths of the present study are the large
number of ART pregnancies in the Conartas cohort, the large
group of control subjects, the population-based design, and
the high data quality in the Nordic health registries (11–14).
Weaknesses include the limited number of mothers of very
advanced reproductive age (>45 years of age), and potential
unmeasured confounders. More than 1,000 women
>40 years of age were included in the ART group, but the
number of events for many outcomes was few, thus
reducing the statistical power in this age category. It was
only possible to adjust for parity, year of birth, offspring
sex, and country. Thus, there may be residual confounding
due to factors such as maternal body mass index, smoking,
and cause of infertility that are not included in the
registries. Smoking and body mass index have previously
been shown to be associated with PTB and SGA in ART
pregnancies (15). Smoking has also been found to be
associated with placental abruption in both ART (15) and in
SC (16) pregnancies. However, in national studies in
Sweden and Norway (17, 18) smoking was less frequent
among ART patients, indicating that smoking can not
explain the higher rate of abruption in ART pregnancies. In
earlier national studies, vanishing twins have been found to
be associated with a poorer neonatal outcome (15, 19),
explaining a part of the poorer outcome for ART singletons.
We could not adjust for vanishing twin or selective
reduction. A large part of the singletons in the present study
were born during a time period where single-embryo transfer
was being performed (in Sweden75% since the early 2000s),
so the contribution of vanishing twins to the general poorer
outcome in ART is small. Selective reduction is an extremely
uncommon procedure in the Nordic countries. Because the
impact of age seemed to be more pronounced in women
who conceived spontaneously it is unlikely that vanishing
twins and selective reduction contributed to the age-related
differences in this study.
Furthermore, a major limitation was that it was not
possible to adjust for socioeconomic variables. Up to 40 years
of age, ART is free of charge or heavily subsidized in the pub-
lic health care system in the Nordic countries. ART treatment
is generally not funded by the state when the woman is
>40 years of age. ART mothers >40 years of age may consti-
tute a socioeconomic group that is economically stronger,
better educated, and healthier than many older SC mothers,
all of which may contribute to the absence of excess risk in
older ART mothers. In all of the Nordic countries, prenatal
care programs are free of charge and provided by the public
health care systems. Reporting births to each country's na-
tional registry is a routine procedure and not dependent on
method of conception. During most of the study period,
women with ART pregnancies have followed the same prena-
tal care programs as the general population. However, older
women with ART pregnancies may be more observant of their
state of health and seek medical attention more often than
other women, which could result in earlier or increased detec-
tion of complications.
A control group from the general population is not an
ideal solution to separate patient characteristics from ART
procedure factors that may be associated with poorer1147
ORIGINAL ARTICLE: ENVIRONMENT AND EPIDEMIOLOGYobstetrical outcomes in ART, because the two populations are
different. Using a subfertile control group or a sibling design
would be more appropriate. Unfortunately, large and com-
plete cohorts of this kind do not exist. A few studies using sib-
ling design have indicated that both patient characteristics
and ART procedures are associated with poorer obstetrical
outcomes (20, 21). The present study question would,
however, not be possible to investigate in such a cohort
using sibling design, even if large, mainly owing to too few
siblings. Furthermore, because age-related risks increased
more in SC than in ART, we do not think that the difference
is explained by infertility or subfertility factors.
This study did not include pregnancies achieved with the
use of oocyte donation (OD). Such pregnancies are associated
with more complications than IVF with own oocytes and can
also be assumed to be more common among older mothers
(22–24). If there are pregnancies as a result of reproductive
tourism, i.e., OD treatments in other countries, they would
incorrectly be assigned as SC pregnancies, contributing to
an age-related risk increase in the SC group. The contribution
of this group of oocyte recipients to the results of the study is,
however, likely to be negligible, considering the large number
of SC pregnancies included.
Only fresh cycles were included for several reasons.
Earlier studies have demonstrated different neonatal out-
comes for children born after frozen and fresh embryo trans-
fer. The risk of PTB and LBW seem to be lower, but the rate of
LGA neonates seems to be higher in singletons born after
frozen embryo transfer than after fresh transfer (25–27).
Moreover, in the present study it was only possible to take
into account the mother's age at the time of embryo
transfer. For fresh cycles, the mother's age at embryo
transfer is the same as the age of the oocytes, whereas for
frozen-thawed cycles a difference of up to 5 years may occur
because legislation in the Nordic countries allows embryos to
be cryopreserved for that length of time. This discrepancy
might complicate the interpretation of age-related risks.
It is well known that advanced maternal age increases the
risk of adverse neonatal and maternal outcomes (2–5).
Furthermore, the risk of maternal complications such as
HDP, placenta previa, and caesarean delivery, as well as the
risk of poor neonatal outcome, is higher among ART
pregnancies (6–8). Few studies have, however, examined the
age-related risks associated specifically with ART concep-
tions. A large American study using data from the Society
for Assisted Reproductive Technology Clinic Online Reporting
System showed decreasing rates of PTB with increasing
maternal age in births resulting from ART (28). Although
not correlated with a control group, that finding is in line
with our results and implies that maternal age is not as strong
a risk factor in ART pregnancies as in SC pregnancies.
Our study included several outcomes and therefore mul-
tiple statistical analyses. The overall test partially corrected
for this. We chose not to further correct for multiple analyses,
which would have reduced the number of randomly inflated
(i.e., false positive) associations, because we thought it was
more important not to increase the number of randomly
deflated (i.e., false negative) associations, which could result
in missing important side-effects of ART (29).1148There may be several reasons for the finding that
although risks of adverse neonatal outcome increase with
age in SC pregnancies, this is not the case, or it is so to a lesser
extent, in women in the ART group. The indications for ART
may be different in older and younger women. ART in older
women may more often be the result of age-related infertility
in otherwise healthy women, whereas younger women are
more likely to have other underlying disorders that can
contribute to increased risks in pregnancy. Women who
conceive through ART at an advanced age may also, for med-
ical and socioeconomic reasons, represent a healthier group
than the general population.CONCLUSION
Although the risk of adverse maternal and neonatal outcomes
was significantly higher in ART than in SC pregnancies for
most maternal ages, the increase in risk with age for adverse
neonatal outcomes was more pronounced in SC. Similar age-
related changes were observed for maternal outcomes in both
ART and SC. The results are important for the large group of
women undergoing ART at an advanced age and for clinicians
treating them.
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SUPPLEMENTAL FIGURE 1
47 992 ART singletons
274 342 SC singletons
108 ART singletons born before 1988
650 SC singletons born before 1988
58 546 ART singletons
332 915 SC singletons
10 464 ART singletons from Finland
58 573 SC singletons from Finland
473 ART singletons with missing values
4209 SC singletons with missing values
47 411 ART singletons
269 483 SC singletons
261 ART singletons with impossible values or combinaons
613 SC singletons with impossible values or combinaons
47 088 ART singletons
268 599 SC singletons
62 ART singletons with extreme values
271 SC singletons with extreme values
6499 ART singletons with cryopreservaon
667 ART singletons with unknown method
39 922 ART singletons
268 599 SC singletons
3 ART singletons in mothers <20 or >46
8433 SC singletons in mothers <20 or >46
39 919 ART singletons
260 166 SC singletons
Flowchart of the study population.
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SUPPLEMENTAL FIGURE 2
Hypertensive disorders in pregnancy for assisted reproductive technology (ART) and spontaneous conception (SC) bymaternal age. OR¼ odds ratio.
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SUPPLEMENTAL FIGURE 3
Placental abruption for assisted reproductive technology (ART) and spontaneous conception (SC) by maternal age. OR ¼ odds ratio.
Wennberg. Age and obstetrical outcome in ART. Fertil Steril 2016.
1149.e3 VOL. 106 NO. 5 / OCTOBER 2016
ORIGINAL ARTICLE: ENVIRONMENT AND EPIDEMIOLOGY
SUPPLEMENTAL FIGURE 4
Placenta previa for assisted reproductive technology (ART) and spontaneous conception (SC) by maternal age. OR ¼ odds ratio.
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SUPPLEMENTAL FIGURE 5
Cesarean section for assisted reproductive technology (ART) and spontaneous conception (SC) by maternal age. OR ¼ odds ratio.
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SUPPLEMENTAL FIGURE 6
Preterm birth <37 weeks for assisted reproductive technology (ART) and spontaneous conception (SC) by maternal age. OR ¼ odds ratio.
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SUPPLEMENTAL FIGURE 7
Preterm birth <32 weeks for assisted reproductive technology (ART) and spontaneous conception (SC) by maternal age. OR ¼ odds ratio.
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SUPPLEMENTAL FIGURE 8
Low birth weight <2,500 g for assisted reproductive technology (ART) and spontaneous conception (SC) by maternal age. OR ¼ odds ratio.
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SUPPLEMENTAL FIGURE 9
Very low birth weight <1,500 g for assisted reproductive technology (ART) and spontaneous conception (SC) by maternal age. OR ¼ odds ratio.
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SUPPLEMENTAL FIGURE 10
Small for gestational age for assisted reproductive technology (ART) and spontaneous conception (SC) by maternal age. OR ¼ odds ratio.
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SUPPLEMENTAL FIGURE 11
Birth weight R4,500 g for assisted reproductive technology (ART) and spontaneous conception (SC) by maternal age. OR ¼ odds ratio.
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SUPPLEMENTAL FIGURE 12
Perinatal mortality R28 weeks for assisted reproductive technology (ART) and spontaneous conception (SC) by maternal age OR ¼ odds ratio.
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SUPPLEMENTAL TABLE 1
Unadjusted odds ratios for maternal and neonatal outcomes for assisted reproductive technologies (ART) versus spontaneous conception at
selected maternal ages.








































































































































Note: Odds ratios are based on piecewise logistic regression. P values are presented for assisted reproductive technologies versus spontaneous conception.
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SUPPLEMENTAL TABLE 2
Association betweenmaternal and neonatal outcomes andmaternal age in assisted reproductive technologies and spontaneous conception: unadjusted odds ratios for event by 5-y increase inmaternal
age.
Outcome








P value<30 y 30 to <35 y 35 to <40 y ‡40 y
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Note: Odds ratios are based on piecewise logistic regression.
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